- Report
- May 2023
- 240 Pages
Global
From €5243EUR$5,500USD£4,469GBP
- Report
- December 2021
- 296 Pages
Global
From €5005EUR$5,250USD£4,266GBP
- Report
- February 2023
- 360 Pages
Global
From €2431EUR$2,550USD£2,072GBP
€2860EUR$3,000USD£2,438GBP
- Report
- November 2021
- 201 Pages
Global
From €4719EUR$4,950USD£4,022GBP
- Report
- May 2023
United States
From €1430EUR$1,500USD£1,219GBP
- Report
- November 2022
- 197 Pages
United States
From €3575EUR$3,750USD£3,047GBP
- Report
- January 2023
- 131 Pages
Global
From €5243EUR$5,500USD£4,469GBP
- Report
- September 2019
- 399 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,235GBP
- Report
- February 2019
- 148 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,235GBP
- Report
- August 2018
- 211 Pages
Global
From €1311EUR$1,375USD£1,117GBP
€2622EUR$2,750USD£2,235GBP
- Report
- August 2018
- 15 Pages
Global
From €596EUR$625USD£508GBP
€1192EUR$1,250USD£1,016GBP
- Report
- October 2019
Global
From €2269EUR$2,380USD£1,934GBP
€2669EUR$2,800USD£2,275GBP
- Report
- May 2023
- 180 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- May 2023
- 160 Pages
Global
From €5672EUR$5,950USD£4,835GBP
- Report
- March 2023
- 116 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Report
- December 2022
- 115 Pages
Global
From €4671EUR$4,900USD£3,982GBP
- Clinical Trials
- September 2021
- 60 Pages
Global
From €1907EUR$2,000USD£1,625GBP
From €2383EUR$2,500USD£2,031GBP
- Report
- October 2021
- 120 Pages
Global
From €2383EUR$2,500USD£2,031GBP
- Report
- May 2023
- 450 Pages
Global
From €4767EUR$5,000USD£4,063GBP
CRISPR Therapeutics is a rapidly growing field within the genomics market. It is a gene-editing technology that uses a modified version of the CRISPR-Cas9 system to modify or replace genes in a living organism. This technology has the potential to revolutionize the way diseases are treated, as it can be used to target and modify specific genes that are responsible for certain diseases. It can also be used to create new treatments for diseases that have no existing treatments.
CRISPR Therapeutics has been used to develop treatments for a variety of diseases, including cancer, cardiovascular disease, and neurological disorders. It has also been used to create new treatments for rare diseases, as well as to develop new therapies for existing diseases.
Companies in the CRISPR Therapeutics market include Editas Medicine, Intellia Therapeutics, CRISPR Therapeutics, and Caribou Biosciences. These companies are working to develop treatments for a variety of diseases, as well as to create new therapies for existing diseases. Show Less Read more